Repurposing Fragile X Drugs to Inhibit SARS-CoV-2 Viral Reproduction

• Cara J. Westmark,
• Maki Kiso,
• Peter Halfmann,
• Pamela R. Westmark,
• Yoshihiro Kawaoka,
• Yoshihiro Kawaoka,
• Yoshihiro Kawaoka

Affiliations

Cara J. Westmark

Department of Neurology, University of Wisconsin–Madison, Madison, WI, United States

Maki Kiso

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Peter Halfmann

Department of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin–Madison, Madison, WI, United States

Pamela R. Westmark

Department of Neurology, University of Wisconsin–Madison, Madison, WI, United States

Yoshihiro Kawaoka

Division of Virology, Department of Microbiology and Immunology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan

Yoshihiro Kawaoka

Department of Pathobiological Sciences, School of Veterinary Medicine, Influenza Research Institute, University of Wisconsin–Madison, Madison, WI, United States

Yoshihiro Kawaoka

Department of Special Pathogens, International Research Center for Infectious Diseases, Institute of Medical Science, The University of Tokyo, Tokyo, Japan